Email Share
Close
E-mail It

NOTE: Recipients' Email Address currently accepts only 5 email addresses separated by commas.

Selected publications

Methods

  • Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-560
  • Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561-570
  • Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the joint effect of non randomized treatments. Journal of the American Statistical Association 2001;96:440-448.
  • Hernán MA, Hernández-Díaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002;155:176-184
  • Hernán MA, Brumback B, Robins JM. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Statistics in Medicine 2002;21:1689-1709.
  • Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004; 15:615-625
  • Hernán MA, Cole SR, Margolick JB,Cohen MH, Robins JM. Structural accelerated failure time models for survival analysis in studies with time-varying treatments. Pharmacoepidemiology and Drug Safety 2005; 14:477-491.
  • Hernán MA, Robins JM, García Rodríguez LA. Discussion on “Statistical issues arising in the Women’s Health Initiative” by Prentice RL et al. Biometrics 2005; 61:922-930
  • Hernán MA, Lanoy E, Costagliola D, Robins JM. Comparison of dynamic treatment regimes via inverse probability weighting. Basic & Clinical Pharmacology & Toxicology 2006; 98:237-242.
  • Hernández-Díaz S, Schisterman EF, Hernán MA. The birth weight paradox uncovered? [with discussion] Am J Epidemiol 2006; 164: 1115-1120
  • Hernán MA, Robins JM. Instruments for causal inference: An epidemiologist’s dream? Epidemiology 2006; 17:360-372
  • Hernán MA, Taubman SL. Does obesity shorten life? The importance of well defined interventions to answer causal questions. International Journal of Obesity 2008; 32:S8-S14.
  • Hernán MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, Manson JE, Robins JM. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease (with discussion). Epidemiology 2008; 19:766-779.
  • Hernán MA, Robins JM. Observational studies analyzed like randomized experiments: Best of both worlds. Epidemiology 2008; 19:789-792
  • Hernán MA,McAdams M, McGrath N, Lanoy E, Costagliola D. Observation plans in longitudinal studies with time-varying treatments. Statistical Methods in Medical Research 2009; 18:27-52.
  • Robins JM, Hernán MA. Estimation of the causal effects of time-varying exposures. In: Advances in Longitudinal Data Analysis. Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, eds. New York: Chapman and Hall/CRC Press, 2009.
  • Hernán MA, Cole SR. Causal diagrams and measurement bias. American Journal of Epidemiology 2009 (in press).

Neuroepidemiology

  • Hernán MA, Olek MJ, Ascherio A. Geographic variation of multiple sclerosis incidence in two prospective cohorts of U.S. women. Neurology 1999;53:1711-8.
  • Hernán MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000;55:848-54.
  • Hernán MA, Zhang SM, Rueda-deCastro AM, Colditz GA, Speizer FE, Ascherio A. Cigarette smoking and the incidence of Parkinson’s disease in two prospective studies. Annals of Neurology 2001;50:780-6.
  • Hernán MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. MAO B intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of Parkinson's disease. Neurology 2002;58:1381-87.
  • Hernán MA, Takkouche B, Caamaño-Isorna P, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Annals of Neurology 2002;52:276-84.
  • Hernán MA, Chen H, Schwarzschild MA, Ascherio A. Alcohol consumption and the incidence of Parkinson's disease. Annals of Neurology 2003;54:170-75.
  • Hernán MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 2004; 63:838-842.
  • Hernán MA, Logroscino G, García Rodríguez LA. A prospective study of alcoholism and the risk of Parkinson’s disease. Journal of Neurology 2004; 251 Suppl 7:14-17.
  • Hernán MA, Jick SS, Olek MJ, Ascherio A, Jick H. Cigarette smoking and progression of multiple sclerosis. Brain 2005; 128: 1461-1465.
  • Hernán MA, Logroscino G, García Rodríguez LA. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson’s disease. Neurology 2006; 66:1097-1099.
  • Hernán MA, Alonso A, Logroscino G. Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology 2008; 19:448-450.